Entera Bio Ltd.

ENTXNasdaq· Biological Products, (No Diagnostic Substances)

Price History

Revenue

$42,000

▼ 76.8% YoY

Net Income

-$11.4M

▼ 19.9% YoY

EPS

$0.25

0.0% YoY

Cash

$7.1M

▼ 17.9% YoY

FY 2025 · As of 2025-12-31

Pro

10-K Year-over-Year Diff

AI-powered analysis of what changed between the last two annual reports — new risks, removed language, strategy shifts.